Stem cell therapy for ischemic heart disease: Where are we?

Current Opinion in Organ Transplantation

Volumn 14, Issue 1, 2009, Pages 79-84

  LaPar, Damien J ^a   Kron, Irving L ^a   Yang, Zequan ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Ischemic heart disease; Review; Stem cell

Indexed keywords

BONE MARROW CELL; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; STEM CELL TRANSPLANTATION; ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; DIAGNOSTIC IMAGING; HEART MUSCLE ISCHEMIA; METHODOLOGY; PARACRINE SIGNALING; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; REGENERATIVE MEDICINE; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIAGNOSTIC IMAGING; HUMANS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 67649229643     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328320d2e2     Document Type: Review

References (42)

1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics: 2008 update - a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117:e25-e146.
2. Xu XQ, Zweigerdt R, Soo SY, et al. Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy 2008; 10:376-389. (Pubitemid 351983161)
3. Leor J, Gerecht S, Cohen S, et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007; 93:1278-1284. (Pubitemid 47492921)
4. Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001; 938:221-229; discussion 229-230. (Pubitemid 32620035)
5. Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, et al. Cardiomyogenic potential of human adult bone marrow mesenchymal stem cells in vitro. Thorac Cardiovasc Surg 2008; 56:77-82.
6. Grauss RW, Winter EM, van Tuyn J, et al. Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. Am J Physiol Heart Circ Physiol 2007; 293:H2438-H2447. (Pubitemid 47605891)
7. Crisostomo PR, Wang M, Markel TA, et al. Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock 2007; 28:375-383. (Pubitemid 47415247)
8. Nakanishi C, Yamagishi M, Yamahara K, et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun 2008; 374:11-16.
9. Rota M, Kajstura J, Hosoda T, et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A 2007; 104:17783-17788. This study demonstrates that BMCs engraft, survive, and proliferate within spared myocardium following infarction through the formation of structurally important junctional complexes with resident myocytes. The results of this study importantly emphasize the therapeutic role of BMCs in the treatment of heart failure. (Pubitemid 350210912)
10. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763-776. (Pubitemid 37186770)
11. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95:911-921. (Pubitemid 39435006)
12. Laugwitz KL, Moretti A, Lam J, et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005; 433:647-653. (Pubitemid 40282999)
13. Planat-Benard V, Menard C, Andre M, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004; 94:223-229. (Pubitemid 38197455)
14. Mazo M, Planat-Benard V, Abizanda G, et al. Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. Eur J Heart Fail 2008; 10:454-462. This study compared cell engraftment, survival, and differentiation as well as cardiac functional outcomes following transplantation of adipose-derived stromal cells (ADSCs) compared with adipose-derived cardiomyoblasts (AD-CMGs) and bone marrow mononuclear cells (BM-MNC). This study importantly demonstrated the superior benefit of transplantation of adipose-derived cells in chronic infarct as compared with cardiac-predifferentiated ADSCs and BM-MNCs.
15. Sadat S, Gehmert S, Song YH, et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun 2007; 363:674-679. (Pubitemid 47513683)
16. Kogler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200:123-135. (Pubitemid 38982172)
17. Moelker AD, Baks T, Wever KM, et al. Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine. J Mol Cell Cardiol 2007; 42:735-745. (Pubitemid 46533979)
18. Mauritz C, Schwanke K, Reppel M, et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 2008; 118:507-517. This study compared the cardiac differentiation potential of murine iPS cells to that of ESCs. The authors importantly demonstrated the successful differentiation of iPS cells into functional cardiomyocytes. This observation may have significant clinical implications for the future of IHD stem cell therapy.
19. Winkler ME, Mauritz C, Groos S, et al. Serum-free differentiation of murine embryonic stem cells into alveolar type II epithelial cells. Cloning Stem Cells 2008; 10:49-64. (Pubitemid 351341553)
20. Narazaki G, Uosaki H, Teranishi M, et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008; 118:498-506.
21. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003; 108:863-868. (Pubitemid 37022130)
22. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006; 355:1222-1232. (Pubitemid 44427446)
23. Saito T, Kuang JQ, Lin CC, Chiu RC. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J Thorac Cardiovasc Surg 2003; 126:114-123. (Pubitemid 36909948)
24. Bartunek J, Dimmeler S, Drexler H, et al. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 2006; 27:1338-1340. (Pubitemid 43998109)
25. Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003; 108:2212-2218. (Pubitemid 37368893)
26. Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006; 27:1114-1122.
27. Menasche P, Alfieri O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008; 117:1189-1200. (Pubitemid 351552018)
28. Fukushima S, Varela-Carver A, Coppen SR, et al. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 2007; 115:2254-2261. (Pubitemid 46685893)
29. Ebert SN, Taylor DG, Nguyen HL, et al. Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells 2007; 25:2936-2944.
30. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17:545-580.
31. Ly HQ, Frangioni JV, Hajjar RJ. Imaging in cardiac cell-based therapy: in vivo tracking of the biological fate of therapeutic cells. Nat Clin Pract Cardiovasc Med 2008; 5 (Suppl 2):S96-S102.
32. Cao F, Lin S, Xie X, et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006; 113:1005-1014.
33. Rosen AB, Kelly DJ, Schuldt AJ, et al. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 2007; 25:2128-2138.
34. Haider HK, Jiang S, Idris NM, Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1{alpha}/CXCR4 signaling to promote myocardial repair. Circ Res 2008; 103:1300-1308.
35. Markel TA, Wang Y, Herrmann JL, et al. VEGF is critical for stem cell mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol 2008 [Epub ahead of print].
36. Du YY, Zhou SH, Zhou T, et al. Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction. Cytotherapy 2008; 10:469-478. This study demonstrated that MSC transplantation inhibits NF-κB activity, attenuates TNF and IL-6, and increases IL-10 expression within infarcted myocardium. This study revealed that MSC transplantation modulated the immunoinflammatory response in myocardial infarction (MI), thus providing myocardial protection.
37. Murtuza B, Suzuki K, Bou-Gharios G, et al. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci U S A 2004; 101:4216-4221. (Pubitemid 38405909)
38. Suzuki K, Murtuza B, Beauchamp JR, et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004; 18:1153-1155. (Pubitemid 39561554)
39. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448:313-317. (Pubitemid 47080336)
40. Pons J, Huang Y, Arakawa-Hoyt J, et al. VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochem Biophys Res Commun 2008; 376:419-422.
41. Boyle AJ, Whitbourn R, Schlicht S, et al. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. Int J Cardiol 2006; 109:21-27.
42. Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451:141-146. This study reported the successful reprogramming of human fibroblasts into human iPS cells through transcription factor expression that resemble ESCs in both morphology and function. This study identifies a potential new source of human stem cells for the treatment of IHD.